Anizon F[au] - Search Results

Year	Number of Results
1997	1
1998	2
1999	3
2000	2
2002	2
2003	2
2005	2
2006	4
2007	6
2008	7
2009	4
2010	6
2011	3
2012	4
2013	2
2014	3
2015	2
2016	4
2019	4
2020	1
2021	2
2022	3
2023	0

1

Synthesis and Kinase Inhibitory Potencies of Pyrazolo[3,4-g]isoquinolines.

Defois M, Rémondin C, Josselin B, Nauton L, Théry V, Anizon F, Ruchaud S, Giraud F, Moreau P. Defois M, et al. Among authors: anizon f. Molecules. 2022 Aug 30;27(17):5578. doi: 10.3390/molecules27175578. Molecules. 2022. PMID: 36080340 Free PMC article.

2

Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors.

Giraud F, Pereira E, Anizon F, Moreau P. Giraud F, et al. Among authors: anizon f. Molecules. 2021 May 4;26(9):2696. doi: 10.3390/molecules26092696. Molecules. 2021. PMID: 34064521 Free PMC article. Review.

3

Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety.

Moreau P, Anizon F, Giraud F, Esvan YJ. Moreau P, et al. Among authors: anizon f. Recent Pat Anticancer Drug Discov. 2016;11(3):309-21. doi: 10.2174/1574892811666160519141628. Recent Pat Anticancer Drug Discov. 2016. PMID: 27194556 Review.

4

Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity.

Zeinyeh W, Esvan YJ, Josselin B, Defois M, Baratte B, Knapp S, Chaikuad A, Anizon F, Giraud F, Ruchaud S, Moreau P. Zeinyeh W, et al. Among authors: anizon f. Eur J Med Chem. 2022 Jun 5;236:114369. doi: 10.1016/j.ejmech.2022.114369. Epub 2022 Apr 9. Eur J Med Chem. 2022. PMID: 35447555

5

Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors.

Anizon F, Shtil AA, Danilenko VN, Moreau P. Anizon F, et al. Curr Med Chem. 2010;17(34):4114-33. doi: 10.2174/092986710793348554. Curr Med Chem. 2010. PMID: 20939820 Review.

6

Synthesis of new pyrazolo[4,3-a]phenanthridine Pim-1 inhibitors and evaluation of their cytotoxic activity towards the MOLM-13 acute myeloid leukemia cell line.

Auvert E, Aesoy R, Giraud F, Herfindal L, Anizon F, Moreau P. Auvert E, et al. Among authors: anizon f. Bioorg Med Chem Lett. 2022 Oct 1;73:128914. doi: 10.1016/j.bmcl.2022.128914. Epub 2022 Jul 30. Bioorg Med Chem Lett. 2022. PMID: 35917834

7

Improved potency of pyridin-2(1H)one derivatives for the treatment of mechanical allodynia.

Visseq A, Descheemaeker A, Hérault K, Giraud F, Abrunhosa-Thomas I, Artola A, Anizon F, Dallel R, Moreau P. Visseq A, et al. Among authors: anizon f. Eur J Med Chem. 2021 Dec 5;225:113748. doi: 10.1016/j.ejmech.2021.113748. Epub 2021 Aug 8. Eur J Med Chem. 2021. PMID: 34392191

8

Pyridin-2(1H)one derivatives: A possible new class of therapeutics for mechanical allodynia.

Visseq A, Descheemaeker A, Pinto-Pardo N, Nauton L, Théry V, Giraud F, Abrunhosa-Thomas I, Artola A, Anizon F, Dallel R, Moreau P. Visseq A, et al. Among authors: anizon f. Eur J Med Chem. 2020 Feb 1;187:111917. doi: 10.1016/j.ejmech.2019.111917. Epub 2019 Nov 26. Eur J Med Chem. 2020. PMID: 31806536

9

Kinase inhibitions in pyrido[4,3-h] and [3,4-g]quinazolines: Synthesis, SAR and molecular modeling studies.

Zeinyeh W, Esvan YJ, Josselin B, Baratte B, Bach S, Nauton L, Théry V, Ruchaud S, Anizon F, Giraud F, Moreau P. Zeinyeh W, et al. Among authors: anizon f. Bioorg Med Chem. 2019 May 15;27(10):2083-2089. doi: 10.1016/j.bmc.2019.04.005. Epub 2019 Apr 4. Bioorg Med Chem. 2019. PMID: 30967303

10

Synthesis and biological activities of isogranulatimide analogues.

Hugon B, Anizon F, Bailly C, Golsteyn RM, Pierré A, Léonce S, Hickman J, Pfeiffer B, Prudhomme M. Hugon B, et al. Among authors: anizon f. Bioorg Med Chem. 2007 Sep 1;15(17):5965-80. doi: 10.1016/j.bmc.2007.05.073. Epub 2007 Jun 7. Bioorg Med Chem. 2007. PMID: 17582773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results